Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

1(33.3%)

N/A

1(33.3%)

Early Phase 1

1(33.3%)

3Total

Phase 2(1)

N/A(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01277445Not ApplicableCompleted

Effects of Fructan Prebiotics on the Intestinal Microbiota

Role: collaborator

NCT01353014Early Phase 1Completed

Genetic Information and Dietary Intake Behaviour

Role: collaborator

NCT01932840Completed

Attitudes and Understanding of Plant Sterol Claims on Food Labels

Role: collaborator

NCT01932827Completed

Attidutes and Understanding of Oat Fibre Claims on Food Labels

Role: collaborator

NCT01764724Completed

Attitudes and Understanding of Sodium Claims on Food Labels

Role: collaborator

NCT01215903Phase 2Completed

Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance

Role: collaborator

All 6 trials loaded